United States
BioStar Capital invests in and nurtures transformative medical technologies. Our team of renowned healthcare clinicians, medical thought leaders, and financial professionals brings unique insight to every investment opportunity. By marshaling a rare combination of domain expertise, industry connections, and access to medical facilities and innovators, BioStar has consistently produced life-changing outcomes for patients and rewarding returns for investors.
34
Total Investments
17
Portfolio Companies
-
Exits
1
Industries
General Information
Industries
Finance
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About BioStar Capital
Recent Investments (34)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series C | •••••• | Feb 2024 | |
| Series B | •••••• | Apr 2023 | |
| Series B | •••••• | Jan 2023 | |
| Series A | •••••• | Oct 2022 | |
| Series B | •••••• | Aug 2022 | |
•••• ••••
|
Series B | •••••• | Jul 2022 |
|
•••• ••••
|
Series D | •••••• | Jun 2022 |
|
•••• ••••
|
Series D | •••••• | Jun 2020 |
|
•••• ••••
|
Series B | •••••• | Feb 2020 |
|
•••• ••••
|
Post-IPO Equity | •••••• | Feb 2019 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.
